CTL Medical to Market G-21 Products in US

By Julie A. Vetalice

CTL Medical entered into an agreement to market G-21 bone cement, kyphoplasty and vertebroplasty products in the U.S.

CTL will begin by distributing G-21's FDA 510(k)-cleared bone cement and kit for kyphoplasty, Winch, which received clearance in 1Q16.

G-21's products complement CTL's own spinal hardware, which includes cervical plates, interbody fusion devices, MIS and disc prep systems, etc. CTL broadened its offerings in 1Q16 with the acquisition of AccelSPINE.

Sources: CTL Medical; ORTHOWORLD Inc.

Product Labels: Vertebroplasty/Kyphoplasty

Tags: M&A